logo
Zhengzhou Phray Technology Co., Ltd.
Principais produtos:Bomba de insulina, NIR dispositivo de terapia, neuropatia dispositivo de terapia, Máquina de ECG e PC-ECG, bomba de infusão
9YRSZhengzhou Phray Technology Co., Ltd.

Visão geral da empresa

Álbum da empresa

Informações básicas
Phray medical is a leading diabetes device manufacturer in China with rich experience over than 15 years,pecializing in manufacturing diabetes and related medical & healthy products, aiming to improve people's life quality and health. Our main products are: insulin pump, Microinfusion pump, NIR therapy device, Neuropathy therapy device, ECG machine, PC-ECG etc. Phray has very rich experience in the Microinfusion field and our insulin pump is the most famous domesticbrand in China. We have powerful professional R&D, QC teams to enable us to serve for our world wide customers with high quality & competitive products and also best OEM/ODM service. We have been keepingclose cooperation with many world famous hospitals, medical agencies and medical device dealers. Phray never stop innovating and making progress. As an experienced manufacturer and exporter in medicalfield, phray is confident to satisfy our worldwide customers. Welcome to contact us, we look forward to working together with you to achieve greater success.
3.6/5
Aceitável
1 Reviews
  • Transações
    -
  • Tempo de resposta
    ≤21h
  • Taxa de resposta
    20%
Tipo de negócio
Fabricante, Trading
País / Região
Henan, China
Principais produtosTotal de funcionários
51 - 100 People
Receita anual total
US$10 Million - US$50 Million
Ano de fundação
2007
Certificações
-
Certificações do produto
-
Patentes
-
Marcas comerciais(1)
Principais mercados

A Capacidade do produto

Informações fábrica

Tamanho da fábrica
Below 1,000 square meters
Localização da fábrica
4/F, No. 84, Jingbei 1st Road, Economic Technology Development Zone, Zhengzhou, Henan. China
Nº das linhas de produção
3
Fabricação de contrato
OEM Service Offered, Design Service Offered, Buyer Label Offered
Valor da produção anual
US$2.5 Million - US$5 Million